You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it. In addition as per local health authority Regulations, some of our products are not approved for sales, marketing or distribution in all countries.
NO
YES

HIGHLIGHTS

CORPORATE

Kedrion announces the appointment of a new CEO

Val Romberg from the USA, one of the most esteemed managers in the industry

read more 

EVENTS

Kedrion supports the 2020 European Hemophilia Consortium Conference

The company renews its commitment alongside the EHC, which continues to support the PARTNERS project

read more 

CORPORATE

KEDPLASMA GmbH changes its name to Kedrion Biopharma GmbH

Further step towards an even stronger focus on patients in Europe

read more 
  1. CORPORATE - 07-04-2020

    Coronavirus, from Plasma an anti Covid-19 treatment

    Kedrion’s commitment to find a treatment from convalescent patient plasma

    read more 
  2. CORPORATE - 20-03-2020

    Letter to patient associations and scientific organizations

    Communication from Paolo Marcucci, Chairman & CEO of Kedrion

    read more 
  3. FEATURED STORIES - 04-01-2020

    In memory of Fabrizio Fabbrizzi

    Written by: Albert Farrugia

    read more 

Pages

For more information please contact: pressoffice@kedrion.com